Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (231-240 of 460) with videos related to

Pageof 46
Sort By:
JCI Insight|April 6, 2018
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenovirusesKeisuke Watanabe, Yanping Luo, Tong Da, et al.
Journal of Translational Medicine|December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Nature Communications|May 10, 2024
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservationAbdulla Berjis, Deeksha Muthumani, Oscar A Aguilar, et al.
Nature Reviews. Rheumatology|August 6, 2024
Advancements and challenges in CAR T cell therapy in autoimmune diseasesGeorg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Cancer|April 15, 2025
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumorsWenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
Cancer Immunology Research|March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignanciesGregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Bioconjugate Chemistry|January 18, 2007
Tat-functionalized near-infrared emissive polymersomes for dendritic cell labelingNatalie A Christian, Michael C Milone, Shraddha S Ranka, et al.
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
Blood|September 3, 2009
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaQing Zhou, Christoph Bucher, Meghan E Munger, et al.
Nature Communications|December 8, 2017
Human CD26<sup>high</sup> T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistenceStefanie R Bailey, Michelle H Nelson, Kinga Majchrzak, et al.
Pageof 46

Showing results (231-240 of 460) with videos related to

Sort By:
Pageof 46
JCI Insight|April 6, 2018
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenovirusesKeisuke Watanabe, Yanping Luo, Tong Da, et al.
Journal of Translational Medicine|December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Nature Communications|May 10, 2024
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservationAbdulla Berjis, Deeksha Muthumani, Oscar A Aguilar, et al.
Nature Reviews. Rheumatology|August 6, 2024
Advancements and challenges in CAR T cell therapy in autoimmune diseasesGeorg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Cancer|April 15, 2025
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumorsWenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
Cancer Immunology Research|March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignanciesGregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Bioconjugate Chemistry|January 18, 2007
Tat-functionalized near-infrared emissive polymersomes for dendritic cell labelingNatalie A Christian, Michael C Milone, Shraddha S Ranka, et al.
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
Blood|September 3, 2009
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaQing Zhou, Christoph Bucher, Meghan E Munger, et al.
Nature Communications|December 8, 2017
Human CD26<sup>high</sup> T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistenceStefanie R Bailey, Michelle H Nelson, Kinga Majchrzak, et al.
Pageof 46